Sign up to save your podcasts
Or
Share ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer
This week’s episode will discuss updates from ASCO 2024 next with the practice changing ADRIATIC trial presented by Dr. Spigel during the plenary: Durvalumab as consolidation treatment for patients with limited-stage small-cell lung cancer (LS-SCLC).
View all episodes
By Sam and Karine
4.8
189189 ratings
This week’s episode will discuss updates from ASCO 2024 next with the practice changing ADRIATIC trial presented by Dr. Spigel during the plenary: Durvalumab as consolidation treatment for patients with limited-stage small-cell lung cancer (LS-SCLC).
More shows like Two Onc Docs
View all
NEJM This Week
324 Listeners
JAMA Clinical Reviews
498 Listeners
Research To Practice | Oncology Videos
120 Listeners
ASCO Daily News
58 Listeners
Mayo Clinic Talks
297 Listeners
The Curbsiders Internal Medicine Podcast
3,357 Listeners
Core IM | Internal Medicine Podcast
1,144 Listeners
OncoPharm
187 Listeners
ASCO Guidelines
43 Listeners
Annals On Call Podcast
191 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Run the List
248 Listeners
Oncology Today with Dr Neil Love
59 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
42 Listeners